-- Chemours (CC) shares were down 16% in Wednesday trading after the company reported lower Q1 earnings, while revenue missed analysts' estimates.
The company posted Q1 adjusted earnings late Tuesday of $0.05 per diluted share, down from $0.13 a year earlier.
Analysts polled by FactSet expected a loss of $0.04.
Net sales for the quarter ended March 31 were $1.38 billion, compared with $1.37 billion a year earlier.
Analysts polled by FactSet expected $1.40 billion.
For Q2, the company expects consolidated net sales to increase in the range of 15% to 20% sequentially, while for 2026, Chemours continues to expect net sales to grow in the range of 3% to 5% over 2025.
Analysts expect Q2 sales of $1.66 billion and 2026 sales of $6.03 billion.
Price: $23.29, Change: $-4.65, Percent Change: -16.64%